Clinical Trials Logo

Carcinoma of Buccal Mucosa clinical trials

View clinical trials related to Carcinoma of Buccal Mucosa.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT02748707 Active, not recruiting - Clinical trials for Oral Squamous Cell Carcinoma

Effect of COX-2 and EGFR Suppression on Molecular Markers of Angiogenesis and Proliferation in Squamous Cell Carcinoma of Oral Cavity - Prospective Randomized Study

ERLO-XIB
Start date: August 18, 2015
Phase: Phase 2
Study type: Interventional

This is a phase II randomized clinical trial to study the effect of COX-2 inhibitor Celecoxib and EGFR tyrosine kinase inhibitor Erlotinib alone or in combination on molecular markers of apoptosis and angiogenesis.